Postprandial Inflammatory Response in Healthy Men: Effect of Dietary Fat Source, Obesity and Age
3 other identifiers
interventional
32
1 country
1
Brief Summary
The nature of dietary lipids, age and perivisceral adiposity could alter the postprandial inflammatory response. It is supposed that there is a relationship between the postprandial inflammatory response and the repartition of fat and lean mass, which could partially explain the muscle mass loss with age. The aim of this study is to compare the inflammatory response of a normal meal or high fat meal (from different fatty acids sources) between young lean and young obese and aged lean and aged obese men.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Mar 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2010
CompletedFirst Posted
Study publicly available on registry
February 10, 2010
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedMarch 25, 2015
January 1, 2011
9 months
February 9, 2010
March 24, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Inflammatory profile by interleukin-6 (IL6) concentration in plasma.
six times per day (kinetic: T0 to T480) on three interventional days
Secondary Outcomes (4)
Muscular strength, Body composition
Once at the first and at the last visit
Total plasma lipids (total cholesterol, HDL-Cholesterol, LDL-cholesterol, Triglycerides (TG), non-esterified fatty acid, Plasma hormonal profile, Plasma inflammatory profile, Markers of Endothelial function, Plasma lipopolysaccharide concentration.
Six times per day (kinetic: T0 to T480), on three interventional days
Pro-inflammatory cytokines expression in subcutaneous adipose tissue
Twice per day (before the meal and 6 hours after), on three interventional days
Urinary metabolomic profile
Three times per days (T0,T240,T480), on three interventional days
Study Arms (3)
mashed potatoes
PLACEBO COMPARATORMashed potatoes is composed of potatoes and Skim milk powder.
Mashed potatoes + Oleic Acid
EXPERIMENTALThe test meal is mashed potatoes with 1g/Kg of weight of lipids with 75% of Oleic Acid
Mashed potatoes + Palmitic Acid
EXPERIMENTALThe test meal is mashed potatoes with 1g/Kg of weight of lipids with 39% of saturated fat with 32% of palmitic acid.
Interventions
Mashed potatoes with 1g/Kg of weight, of lipids with 75% of Oleic Acid
Mashed potatoes with 1g/Kg of weight, of lipids with 32% of palmitic acid
Eligibility Criteria
You may qualify if:
- Subject giving his written informed consent
- Male from 20 to 35 years old and more than 60
- Affiliated to the French National Health Insurance
- Body mass index (BMI) ≤ 25kg/m² and waist circumference ≤94cm ; or BMI ≥ 28kg/m² and waist circumference ≥ 102cm.
- Complete blood count (CBC)-platelet, normal liver function and normal coagulation.
- Serology of Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) negative
- normal Thyroid Stimulating Hormone(TSH)
You may not qualify if:
- Previous medical and/or surgery judged by the investigator as incompatible with this study
- Glaucoma
- C-reactive protein \> 10 mg/l
- people over 120 kg
- People with triglyceridemia \> 3 g/L or with familial hypercholesterolemia
- Fasting glycemia \> 1,26 g/l, abnormal Oral Glucose Tolerance Test
- Dietary habits judged by the dietitian as incompatible with the study aim
- Vegetarians
- Nutritional allergies or xylocaïn allergy
- People with eating disorders
- Heavy consumer of alcohol or cigarette
- Practising intensive physical exercise
- People with medication that could interfere with the measured parameters: beta-blockers, statins, anticoagulants, antiplatelet agents, corticosteroids for more than 8 days.
- Depression or psychiatric treatment
- Being under someone's supervision
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yves Boirielead
- Centre de Recherche en Nutrition Humaine d'Auvergnecollaborator
- ITERGcollaborator
Study Sites (1)
Human nutrition laboratory
Clermont-Ferrand, Auvergne, 63000, France
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yves Boirie, MD/PhD
CRNH
- STUDY DIRECTOR
Stephane Walrand, PhD
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PhD, Pr Yves Boirie
Study Record Dates
First Submitted
February 9, 2010
First Posted
February 10, 2010
Study Start
March 1, 2010
Primary Completion
December 1, 2010
Study Completion
January 1, 2011
Last Updated
March 25, 2015
Record last verified: 2011-01